CN Stock MarketDetailed Quotes

688266 Suzhou Zelgen Biopharmaceuticals

Watchlist
  • 56.47
  • -1.08-1.88%
Market Closed Aug 23 15:00 CST
14.95BMarket Cap-64759P/E (TTM)

Suzhou Zelgen Biopharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Suzhou Zelgen Biopharmaceuticals Q2 2024 Earnings Date

Currency：CNYAug 24, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
132.45M
--
+18.45%
Net Income
--
-32.90M
--
+46.01%
Analyst Rating
Strong Buy

Aug 24, 2024

Suzhou Zelgen Biopharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.347B--
--2024/FY-- / 742.815M--
--2023/FY386.439M / 429.000M--
--2021/FY190.361M / 208.000M--
--2020/FY27.661M / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.347B--
--2024/FY-- / 742.815M--
--2023/FY386.439M / 429.000M--
--2021/FY190.361M / 208.000M--
--2020/FY27.661M / 0.000--

Unlock Free Earnings Estimates

Suzhou Zelgen Biopharmaceuticals Earnings Reports

  • ZeJing Pharmaceutical's 2024 interim report

    12:00 ET

  • Summary of Zejing Pharmaceuticals' semi-annual report for 2024

    12:00 ET

  • Zejing Pharmaceutical 2023 Annual Report

    Apr 19 12:00 ET

  • Summary of Zejing Pharmaceutical's 2023 Annual Report

    Apr 19 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 24, 2024

    Strong Buy

    • Strong Buy

      92.31%

    • Buy

      7.69%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg